Neuropathology-based risk scoring for dementia diagnosis in the elderly
- PMID: 19542615
- PMCID: PMC2852462
- DOI: 10.3233/JAD-2009-1105
Neuropathology-based risk scoring for dementia diagnosis in the elderly
Abstract
Current neuropathologic consensus criteria for diagnosis of dementia yield a classification of processes that likely contributed to dementia in that individual. While dementia diagnosis currently relies on clinical criteria, practicing neuropathologists and researchers might benefit from a simple, accurate risk scoring protocol for the neuropathologic diagnosis of dementia. Using 232 consecutive autopsies from the population-based Adult Changes in Thought study, we developed two logistic regression-based risk scoring systems; one solely using neuropathologic measures and a second additionally including demographic information. Inverse-probability weighting was used to adjust for inherent selection bias in autopsy-based studies of dementing illnesses. Both systems displayed high levels of predictive accuracy; bias-adjusted area-under-the-curve statistics were 0.78 (95% CI 0.71, 0.85) and 0.87 (95% CI 0.83, 0.92), indicating improved performance with the inclusion of demographic characteristics, specifically age and birth cohort information. Application of the combined neuropathology/demographic model yielded bias-adjusted sensitivity and specificity of 81% each. In contrast, application of NIA-Reagan criteria yielded sensitivity and specificity of 53% and 84%. Our proposed scoring systems provide neuropathologists with tools to make a diagnosis, and interpret their diagnosis in the light of known sensitivity and specificity estimates. Evaluation in independent samples will be important to verify our findings.
Figures
Similar articles
-
Neuropathology of older persons without cognitive impairment from two community-based studies.Neurology. 2006 Jun 27;66(12):1837-44. doi: 10.1212/01.wnl.0000219668.47116.e6. Neurology. 2006. PMID: 16801647 Clinical Trial.
-
Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2. Cochrane Database Syst Rev. 2021. PMID: 33566374 Free PMC article.
-
Comparative Performance and Neuropathologic Validation of the AD8 Dementia Screening Instrument.Alzheimer Dis Assoc Disord. 2020 Apr-Jun;34(2):112-117. doi: 10.1097/WAD.0000000000000362. Alzheimer Dis Assoc Disord. 2020. PMID: 31725472 Free PMC article.
-
Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.J Alzheimers Dis. 2017;58(2):435-448. doi: 10.3233/JAD-160374. J Alzheimers Dis. 2017. PMID: 28453469 Free PMC article.
-
Mini-Cog for the detection of dementia within a secondary care setting.Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011414. doi: 10.1002/14651858.CD011414.pub3. Cochrane Database Syst Rev. 2021. PMID: 34260060 Free PMC article.
Cited by
-
Methods to Address Self-Selection and Reverse Causation in Studies of Neighborhood Environments and Brain Health.Int J Environ Res Public Health. 2021 Jun 16;18(12):6484. doi: 10.3390/ijerph18126484. Int J Environ Res Public Health. 2021. PMID: 34208454 Free PMC article. Review.
-
A History of Senile Plaques: From Alzheimer to Amyloid Imaging.J Neuropathol Exp Neurol. 2022 May 20;81(6):387-413. doi: 10.1093/jnen/nlac030. J Neuropathol Exp Neurol. 2022. PMID: 35595841 Free PMC article.
-
Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.J Alzheimers Dis. 2021;79(1):389-400. doi: 10.3233/JAD-201213. J Alzheimers Dis. 2021. PMID: 33285640 Free PMC article.
-
Integrated multimodal cell atlas of Alzheimer's disease.Res Sq [Preprint]. 2023 May 23:rs.3.rs-2921860. doi: 10.21203/rs.3.rs-2921860/v1. Res Sq. 2023. Update in: Nat Neurosci. 2024 Dec;27(12):2366-2383. doi: 10.1038/s41593-024-01774-5. PMID: 37292694 Free PMC article. Updated. Preprint.
-
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.J Neuropathol Exp Neurol. 2011 Sep;70(9):788-98. doi: 10.1097/NEN.0b013e31822c62cf. J Neuropathol Exp Neurol. 2011. PMID: 21865887 Free PMC article.
References
-
- Hyman B, Trojanowski J. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease from The National Institute on Aging Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging. 1997;18:S1–2. - PubMed
-
- Vinters HV. Surgical pathologic findings of extratemporal-based intractable epilepsy. A study of 133 consecutive cases. Arch Pathol Lab Med. 2000;124:1111–1112. - PubMed
-
- Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–436. - PubMed
-
- Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75–80. - PubMed
-
- Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L, White LR. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol. 2005;57:98–103. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical